Abstract
Objective
To review the management of epilepsy in patients with tuberous sclerosis complex (TSC) with an emphasis on surgical aspects, neuropathology, and pathogenesis.
Methods
Review of the literature and presentation of the authors’ experience of surgery for refractory epilepsy in patients with TSC.
Results
TSC is a multisystem genetic disorder with variable phenotypic expression. TSC results from a mutation in the TSC1 gene on chromosome 9, which codes for hamartin, or in the TSC 2 gene on chromosome 16 which codes for tuberin. The majority of the patients have TSC as a result of spontaneous genetic mutations while in one-third of the patients, the disorder is inherited in an autosomal dominant manner. Epilepsy is the most common neurological complication, and up to 80–90% of individuals with TSC develop epilepsy at some point in their lifetime. The onset of epilepsy is typically in early childhood. Infantile spasms are a very common early seizure type although partial seizures may occur. Developmental delay, intellectual impairment, autism, behavioral problems, and neuropsychiatric disorders occur commonly in individuals with TSC and may be associated with poorly controlled epilepsy. Antiepileptic drugs are the first-line management for epilepsy but the ketogenic diet, resection of one or more tubers, corpus callosotomy, and vagus nerve stimulation are other therapeutic options for individuals with poorly controlled epilepsy.
Similar content being viewed by others
References
Aicardi J, Mumford JP, Dumas C, Wood S (1996) Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups. Epilepsia 37:638–642
Anonymous (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium. Cell 75:1305–1315
Asano E, Chugani DC, Muzik O et al (2000) Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54:1976–1984
Asano E, Chugani DC, Muzik O et al (2001) Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology 57:1269–1277
Avellino AM, Berger MS, Rostomily RC, Shaw CM, Ojemann GA (1997) Surgical management and seizure outcome in patients with tuberous sclerosis. J Neurosurg 87:391–396
Bebin EM, Kelly PJ, Gomez MR (1993) Surgical treatment for epilepsy in cerebral tuberous sclerosis. Epilepsia 34:651–657
Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A (2002) Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 125:1247–1255
Bonnin JM, Rubinstein LJ, Papasozomenos SC, Marangos PJ (1984) Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study. Acta Neuropathol (Berl) 62:185–193
Burger PC, Scheithauer BW (1994) Tumors of the central nervous system. In: Anonymous (ed) Atlas of tumor pathology, series 3. Armed Forces Institute of Pathology, Washington, DC
Carbonara C, Longa L, Grosso E et al (1996) Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer 15:18–25
Chiron C, Dumas C, Jambaque I, Mumford J, Dulac O (1997) Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26:389–395
Chou TM, Chou SM (1989) Tuberous sclerosis in the premature infant: a report of a case with immunohistochemistry on the CNS. Clin Neuropathol 8:45–52
Chugani DC, Chugani HT, Muzik O et al (1998) Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 44:858–866
Curatolo P, Brinchi V (1993) Antenatal diagnosis of tuberous sclerosis. Lancet 341:176–177
Curatolo P, Cusmai R, Cortesi F, Chiron C, Jambaque I, Dulac O (1991) Neuropsychiatric aspects of tuberous sclerosis. Ann NY Acad Sci 615:8–16
Cusmai R, Chiron C, Curatolo P, Dulac O, Tran-Dinh S (1990) Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis. Epilepsia 31:747–755
Ferrer I, Fabregues I, Coll J, Ribalta T, Rives A (1984) Tuberous sclerosis: a Golgi study of cortical tuber. Clin Neuropathol 3:47–51
Franz DN, Tudor C, Leonard J et al (2001) Lamotrigine therapy of epilepsy in tuberous sclerosis. Epilepsia 42:935–940
Fukushima K, Inoue Y, Fujiwara T, Yagi K (2001) Long-term follow-up study of West syndrome associated with tuberous sclerosis. Brain Dev 23:698–704
Ganji S, Hellman CD (1985) Tuberous sclerosis: long-term follow-up and longitudinal electroencephalographic study. Clin Electroencephalogr 16:219–224
Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63:1457–1461
Gomez MR (1999) Natural history of cerebral tuberous sclerosis. In: Gomez MR, Sampson JR, Whittemore VH (eds) Tuberous sclerosis complex (Developmental perspectives in psychiatry), 3rd edn. Oxford University Press, New York, pp 29–46
Goodman M, Lamm SH, Engel A, Shepherd CW, Houser OW, Gomez MR (1997) Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol 12:85–90
Green AJ, Smith M, Yates JR (1994) Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6:193–196
Guerreiro MM, Andermann F, Andermann E et al (1998) Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients. Neurology 51:1263–1269
Hamano S, Tanaka M, Mochizuki M, Sugiyama N, Eto Y (2003) Long-term follow-up study of West syndrome: differences of outcome among symptomatic etiologies. J Pediatr 143:231–235
Hancock E, Osborne JP (1999) Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 14:71–74
Harding GF, Wild JM, Robertson KA et al (2000) Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia 41:1420–1431
Harding GF, Wild JM, Robertson KA, Rietbrock S, Martinez C (2000) Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology 55:347–352
Hirano A, Tuazon R, Zimmerman HM (1968) Neurofibrillary changes, granulovacuolar bodies and argentophilic globules observed in tuberous sclerosis. Acta Neuropathol (Berl) 11:257–261
Hirose T, Scheithauer BW, Lopes MB et al (1995) Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathol (Berl) 90:387–399
Hunt A (1993) Development, behaviour and seizures in 300 cases of tuberous sclerosis. J Intellect Disabil Res 37(Pt 1):41–51
Huttenlocher PR, Heydemann PT (1984) Fine structure of cortical tubers in tuberous sclerosis: a Golgi study. Ann Neurol 16:595–602
Jambaque I, Cusmai R, Curatolo P, Cortesi F, Perrot C, Dulac O (1991) Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings. Dev Med Child Neurol 33:698–705
Jansen FE, Braun KP, van Nieuwenhuizen O et al (2003) Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis. Arch Neurol 60:1580–1584
Jarrar RG, Buchhalter JR, Raffel C (2004) Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology 62:479–481
Johnson MW, Kerfoot C, Bushnell T, Li M, Vinters HV (2001) Hamartin and tuberin expression in human tissues. Mod Pathol 14:202–210
Joinson C, O’Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF (2003) Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 33:335–344
Jozwiak S, Goodman M, Lamm SH (1998) Poor mental development in patients with tuberous sclerosis complex: clinical risk factors. Arch Neurol 55:379–384
Kagawa K, Chugani DC, Asano E et al (2005) Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol 20:429–438
Kawai K, Shimizu H, Yagishita A, Maehara T, Tamagawa K (2004) Clinical outcomes after corpus callosotomy in patients with bihemispheric malformations of cortical development. J Neurosurg 101:7–15
Koh S, Jayakar P, Resnick T, Alvarez L, Liit RE, Duchowny M (1999) The localizing value of ictal SPECT in children with tuberous sclerosis complex and refractory partial epilepsy. Epileptic Disord 1:41–46
Koh S, Jayakar P, Dunoyer C et al (2000) Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia 41:1206–1213
Lachhwani DK, Pestana E, Gupta A, Kotagal P, Bingaman W, Wyllie E (2005) Identification of candidates for epilepsy surgery in patients with tuberous sclerosis. Neurology 64:1651–1654
Lamb RF, Roy C, Diefenbach TJ et al (2000) The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2:281–287
Lazarowski A, Lubieniecki F, Camarero S et al (2004) Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol 30:102–106
Miloloza A, Rosner M, Nellist M, Halley D, Bernaschek G, Hengstschlager M (2000) The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum Mol Genet 9:1721–1727
Mizuguchi M, Ikeda K, Takashima S (2000) Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathol (Berl) 99:503–510
Morimoto K, Mogami H (1986) Sequential CT study of subependymal giant-cell astrocytoma associated with tuberous sclerosis. Case report. J Neurosurg 65:874–877
`Nellist M, van Slegtenhorst MA, Goedbloed M, van den Ouweland AM, Halley DJ, van der Sluijs P (1999) Characterization of the cytosolic tuberin–hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J Biol Chem 274:35647–35652
Nixon JR, Houser OW, Gomez MR, Okazaki H (1989) Cerebral tuberous sclerosis: MR imaging. Radiology 170:869–873
Ohtsuka Y, Ohmori I, Oka E (1998) Long-term follow-up of childhood epilepsy associated with tuberous sclerosis. Epilepsia 39:1158–1163
Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann NY Acad Sci 615:125–127
Parain D, Penniello MJ, Berquen P, Delangre T, Billard C, Murphy JV (2001) Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 25:213–216
Plank TL, Logginidou H, Klein-Szanto A, Henske EP (1999) The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod Pathol 12:539–545
Richardson EP Jr (1991) Pathology of tuberous sclerosis. Neuropathologic aspects. Ann NY Acad Sci 615:128–139
Rintahaka PJ, Chugani HT (1997) Clinical role of positron emission tomography in children with tuberous sclerosis complex. J Child Neurol 12:42–52
Roach ES, Williams DP, Laster DW (1987) Magnetic resonance imaging in tuberous sclerosis. Arch Neurol 44:301–303
Romanelli P, Verdecchia M, Rodas R, Seri S, Curatolo P (2004) Epilepsy surgery for tuberous sclerosis. Pediatr Neurol 31:239–247
Sharp D, Robertson DM (1983) Tuberous sclerosis in an infant of 28 weeks gestational age. Can J Neurol Sci 10:59–62
Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschlager M (1997) Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem 272:29301–29308
Szelies B, Herholz K, Heiss WD et al (1983) Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: demonstration by positron emission tomography. J Comput Assist Tomogr 7:946–953
Takanashi J, Sugita K, Fujii K, Niimi H (1995) MR evaluation of tuberous sclerosis: increased sensitivity with fluid-attenuated inversion recovery and relation to severity of seizures and mental retardation. AJNR Am J Neuroradiol 16:1923–1928
Thiele EA (2004) Managing epilepsy in tuberous sclerosis complex. J Child Neurol 19:680–686
Van Bogaert L, Paillas JE, Berard-Badier, Payan H (1958) Etude sur la sclerose tubereuse de Bourneville a forme cerebelleuse. Rev Neurol (Paris) 98:673–689
van Slegtenhorst M, de Hoogt R, Hermans C et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808
van Slegtenhorst M, Nellist M, Nagelkerken B et al (1998) Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 7:1053–1057
Weiner HL (2004) Tuberous sclerosis and multiple tubers: localizing the epileptogenic zone. Epilepsia 45(Suppl 4):41–42
Westmoreland B (1999) The electroencephalogram in tuberous sclerosis. In: Gomez MR, Sampson JR, Whittemore VH (eds) Tuberous sclerosis complex: developmental perspectives in psychiatry, 3rd edn. Oxford University Press, New York, pp 63–74
White R, Hua Y, Scheithauer B, Lynch DR, Henske EP, Crino PB (2001) Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 49:67–78
Wong M, Ess KC, Uhlmann EJ et al (2003) Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol 54:251–256
Yamanouchi H, Jay V, Rutka JT, Takashima S, Becker LE (1997) Evidence of abnormal differentiation in giant cells of tuberous sclerosis. Pediatr Neurol 17:49–53
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Connolly, M.B., Hendson, G. & Steinbok, P. Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects. Childs Nerv Syst 22, 896–908 (2006). https://doi.org/10.1007/s00381-006-0130-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-006-0130-7